Science Explorer Interactive view Map
Company · Uppsala · Sweden

Novavax (Sweden)

novavax.comROR OpenAlex
Research works
8
▼ 39% vs 2013–17
Citations
390
51.9 per fractional work
Top-10% rate
56.8%
record average 16.5%
Open access
87%
world 28%

Not ranked overall: Novavax (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.84× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 34.82× its world share, 1 worksImmunology and Micro…Chemical Engineering: 10.03× its world share, 0 worksChemical EngineeringChemistry: 1.12× its world share, 0 worksChemistryHealth Professions: 0.50× its world share, 0 worksHealth ProfessionsMedicine: 1.74× its world share, 1 worksMedicineVeterinary: 38.73× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 2.11× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 38.7×. Every wedge is a field page.

Which research topics does Novavax (Sweden) publish most on?

By volume in 2022–2025: Malaria Research and Control, Immune Response and Inflammation, Immunotherapy and Immune Responses and Veterinary medicine and infectious diseases.

Malaria Research and Control: 0 fractional worksImmune Response and Inflammation: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksVeterinary medicine and infectious diseases: 0 fractional worksViral gastroenteritis research and epidemiology: 0 fractional worksMosquito-borne diseases …0Mosquito-borne diseases and control: 0 fractional worksHIV Research and Treatment: 0 fractional worksInflammasome and immune disorders: 0 fractional worksKawasaki Disease and Coronary Complications: 0 fractional worksStreptococcal Infections and Treatments: 0 fractional works
Public Health, Environmental and Occupational HealthImmunologySmall AnimalsInfectious Diseases3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Malaria Research and Control Public Health, Environmental and Occupational Health 0 works
  2. 2 Immune Response and Inflammation Immunology 0 works
  3. 3 Immunotherapy and Immune Responses Immunology 0 works
  4. 4 Veterinary medicine and infectious diseases Small Animals 0 works
  5. 5 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  6. 6 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
  7. 7 HIV Research and Treatment Virology 0 works
  8. 8 Inflammasome and immune disorders Molecular Biology 0 works
  9. 9 Kawasaki Disease and Coronary Complications Surgery 0 works
  10. 10 Streptococcal Infections and Treatments Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available86.6%not open13.4%

World: 28% of research is openly available.

with international co-authors92.1%domestic only7.9%

World: 19% is written across borders.

How has Novavax (Sweden)'s research output changed?

Output in 2018–2022 was 39% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Uppsala

All research institutions in Uppsala

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.